MD3250182T2 - Compoziții dispersabile - Google Patents

Compoziții dispersabile

Info

Publication number
MD3250182T2
MD3250182T2 MDE20170303T MDE20170303T MD3250182T2 MD 3250182 T2 MD3250182 T2 MD 3250182T2 MD E20170303 T MDE20170303 T MD E20170303T MD E20170303 T MDE20170303 T MD E20170303T MD 3250182 T2 MD3250182 T2 MD 3250182T2
Authority
MD
Moldova
Prior art keywords
compositions
dispersible compositions
dispersible
useful
pediatric
Prior art date
Application number
MDE20170303T
Other languages
English (en)
Inventor
Manish Kumar Gupta
Shripad Wasudeo Marathe
Kaustubh Ramesh Tambwekar
Shreedevi Velayudhan Nair
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MD3250182T2 publication Critical patent/MD3250182T2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

Prezenta invenţie se referă la compoziţii dispersabile, care cuprind fumarat de bedachilină ca ingredient activ. Astfel de compoziţii sunt utile în tratamentul tuberculozei, iar proprietăţile lor inerente de dispersabilitate se pretează să fie utile în special în rândul populaţiei pediatrice sau geriatrice.
MDE20170303T 2015-01-27 2016-01-26 Compoziții dispersabile MD3250182T2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN264MU2015 2015-01-27
PCT/EP2016/051545 WO2016120258A1 (en) 2015-01-27 2016-01-26 Dispersible compositions

Publications (1)

Publication Number Publication Date
MD3250182T2 true MD3250182T2 (ro) 2023-09-30

Family

ID=55229712

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20170303T MD3250182T2 (ro) 2015-01-27 2016-01-26 Compoziții dispersabile

Country Status (29)

Country Link
US (2) US20180000810A1 (ro)
EP (1) EP3250182B1 (ro)
JP (3) JP7291458B2 (ro)
KR (1) KR102631986B1 (ro)
CN (2) CN114129526A (ro)
AU (2) AU2016212116B2 (ro)
CA (1) CA2973301A1 (ro)
CY (1) CY1126107T1 (ro)
DK (1) DK3250182T3 (ro)
EA (1) EA201791701A1 (ro)
ES (1) ES2948805T3 (ro)
FI (1) FI3250182T3 (ro)
HK (1) HK1243644A1 (ro)
HR (1) HRP20230616T1 (ro)
HU (1) HUE062481T2 (ro)
IL (2) IL310920A (ro)
LT (1) LT3250182T (ro)
MA (1) MA41411B1 (ro)
MD (1) MD3250182T2 (ro)
MX (1) MX2017009681A (ro)
PE (1) PE20171319A1 (ro)
PH (1) PH12017501331A1 (ro)
PL (1) PL3250182T3 (ro)
PT (1) PT3250182T (ro)
RS (1) RS64308B1 (ro)
SG (1) SG11201705944TA (ro)
SI (1) SI3250182T1 (ro)
UA (1) UA126891C2 (ro)
WO (1) WO2016120258A1 (ro)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
MD3651736T2 (ro) 2017-07-14 2021-12-31 Janssen Pharmaceutica Nv Formulări cu acțiune prelungită
EP3773731A1 (en) * 2018-04-05 2021-02-17 Cipla Limited Pharmaceutical formulations
US11291654B2 (en) * 2018-09-13 2022-04-05 Syneurx International (Taiwan) Corp. Formulations of cycloserine compounds and applications thereof
US20220023282A1 (en) * 2018-12-13 2022-01-27 Mannkind Corporation Compositions of Bedaquiline, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them
WO2020144197A1 (en) * 2019-01-09 2020-07-16 Janssen Pharmaceutica Nv Combination in the treatment of nontuberculous mycobacterial diseases
CN111888477B (zh) * 2020-09-15 2023-03-07 北京福元医药股份有限公司 一种贝达喹啉药物制剂
KR102478006B1 (ko) 2020-12-03 2022-12-15 정승찬 자동차 긴급 제동장치
US11793808B2 (en) 2021-02-22 2023-10-24 Mannkind Corp. Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
GB202211231D0 (en) 2022-08-02 2022-09-14 Glaxosmithkline Ip No 2 Ltd Novel formulation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1527050B1 (en) 2002-07-25 2010-04-07 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors
SI1753427T1 (sl) 2004-05-28 2008-10-31 Janssen Pharmaceutica Nv Uporaba substituiranih kinolinskih derivatov za zdravljenje na zdravila odpornih mikobakterijskih bolezni
EE05394B1 (et) 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
NZ563819A (en) * 2005-05-25 2011-01-28 Janssen Pharmaceutica Nv Process for preparing (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-napthalenyl-beta-phenyl-3-quinolineethanol (R207910)
EE05697B1 (et) * 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Kinoliini derivaadid kui antibakteriaalsed toimeained
TW200815033A (en) * 2006-08-10 2008-04-01 Cipla Ltd Antiretroviral solid oral composition
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
US20110159084A1 (en) * 2008-04-02 2011-06-30 Dr. Reddy's Laboratories Ltd. Raloxifene pharmaceutical formulations
BRPI0918802A2 (pt) * 2008-09-03 2019-09-17 Pfizer uso de (s)-n-[[3-[3-fluoro-4-(4-tiomorfolinil)fenil]-2-oxo-5-oxazolidinil] metil] acetamida e composição farmacêutica
US20120207838A1 (en) * 2011-02-10 2012-08-16 Perricone Nicholas V Treatment of Psoriasis Using Oral Dosage Forms of Nitrone Spin Traps
WO2013153162A1 (en) * 2012-04-11 2013-10-17 Sandoz Ag Polymorph of rilpivirine hydrochloride
US20140075692A1 (en) * 2012-09-18 2014-03-20 Unger Marketing International, Llc. Multiuse cleaning tool handle
MX2015006217A (es) * 2012-11-19 2015-11-16 Azanta As Tableta dispersable.

Also Published As

Publication number Publication date
LT3250182T (lt) 2023-07-10
CN114129526A (zh) 2022-03-04
IL253626B1 (en) 2024-04-01
CA2973301A1 (en) 2016-08-04
DK3250182T3 (da) 2023-06-26
BR112017015784A2 (pt) 2018-03-27
SG11201705944TA (en) 2017-08-30
KR102631986B1 (ko) 2024-01-30
JP2022176982A (ja) 2022-11-30
RS64308B1 (sr) 2023-07-31
ES2948805T3 (es) 2023-09-19
JP2021098706A (ja) 2021-07-01
HUE062481T2 (hu) 2023-11-28
IL253626A0 (en) 2017-09-28
AU2016212116A1 (en) 2017-07-27
MA41411A (fr) 2017-12-05
JP7291458B2 (ja) 2023-06-15
HRP20230616T1 (hr) 2023-09-29
KR20170106447A (ko) 2017-09-20
FI3250182T3 (fi) 2023-06-28
EP3250182A1 (en) 2017-12-06
EA201791701A1 (ru) 2017-11-30
MA41411B1 (fr) 2023-07-31
MX2017009681A (es) 2017-10-18
PE20171319A1 (es) 2017-09-07
JP2018502928A (ja) 2018-02-01
US20220331307A1 (en) 2022-10-20
US20180000810A1 (en) 2018-01-04
IL310920A (en) 2024-04-01
SI3250182T1 (sl) 2023-08-31
WO2016120258A1 (en) 2016-08-04
PL3250182T3 (pl) 2023-07-31
UA126891C2 (uk) 2023-02-22
EP3250182B1 (en) 2023-04-26
AU2021204135B2 (en) 2023-10-05
CN107205945A (zh) 2017-09-26
AU2016212116B2 (en) 2021-07-15
CY1126107T1 (el) 2023-11-15
PT3250182T (pt) 2023-07-07
PH12017501331A1 (en) 2017-12-11
AU2021204135A1 (en) 2021-07-15
HK1243644A1 (zh) 2018-07-20

Similar Documents

Publication Publication Date Title
MD3250182T2 (ro) Compoziții dispersabile
EA201890201A1 (ru) Антибактериальные соединения
EA201990043A1 (ru) Антибактериальные соединения
AU2018285213A1 (en) Herbicidally active 3-phenylisoxazoline-5-carboxamides of tetrahydro and dihydrofuran carboxamides
NZ733174A (en) Quinazoline derivatives used to treat hiv
MX362140B (es) Combinaciones de alquilamidotiazoles y agentes conservantes.
EA201790273A1 (ru) Флагеллиновые композиции и их применение
TR201901077T4 (tr) Kanser Veya Enfeksiyon Tedavisine Yönelik Birleşik Preparasyonlar
NZ733125A (en) Isoquinoline compounds for the treatment of hiv
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
EA201990044A1 (ru) Гетероциклические соединения в качестве антибактериальных средств
EA201500383A1 (ru) Производные 1,2,4-триазина для лечения вирусных инфекций
PH12018500315A1 (en) Fumagillol heterocyclic compounds and methods of making and using same
CL2016001918A1 (es) Heteroaril amidas como inhibidores de agregación de proteína
CL2015002897A1 (es) Inhibidores de bace1
BR112014027981A2 (pt) compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
BR112018013761A2 (pt) compostos antiproliferativos e suas composições farmacêuticas e usos
BR112018071831A2 (pt) composições anti-irritantes sinérgicas de taurina e aloé e métodos
BR112014014319A2 (pt) composições de cuidado oral
MX2017003928A (es) Composiciones farmaceuticas de accion prolongada.
MX2018000570A (es) Nuevas isoformas de tripsina y su uso.
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
BR112019001131A2 (pt) composto virucida, composição farmacêutica, método de desinfecção e/ou esterilização, dispositivo e uso dos compostos virucidas
MX2015011991A (es) Combinaciones de alquilamidotiazoles y sustancias aromaticas.
BR112016013600A2 (pt) Peptídeo antimicrobiano e seus usos